Janssen Pharmaceuticals has signed a collaboration agreement with the National Taiwan University (NTU) and the university’s hospital (NTUH) to cooperate on developing new drugs for treating hepatitis B. Despite the high success rate of viral suppression achieved by existing medications, the virus is currently incurable.
Chen Ding-shinn (陳定信), chair professor at National Taiwan University Medical College, said that there are more than 350 million people in the world infected with the hepatitis B virus (HBV), 60 to 70 percent of which are in Asia.
Every year, more than 600 thousand people die as a result of complications such as liver cirrhosis and liver cancer caused by the virus.
“HBV can be transmitted prenatally [from mother to child] or by having contact with an infected person. While less than 3 percent of adults infected with the virus develop chronic hepatitis, more than 90 percent of infected newborns do,” Chen said. “Those who have chronic or persistent hepatitis B are at a high risk of developing liver cirrhosis or liver cancer later in life.”
There are about 2.4 million HBV carriers in Taiwan, Chen said, adding that statistics in 2011 showed that deaths attributable to liver cancer ranked No. 2 on the list of leading causes of death for men and women.
“Eighty percent to 90 percent of liver cancer patients had chronic hepatitis B,” he said.
“However, after Taiwan started vaccinating newborns against HBV in 1984, the number of yearly infections has decreased,” Chen said.
While the nation’s vaccination plan is an effective prevention measure, “having better control over the source of infection is still out of reach. Interferon, an approved medication for treating HBV infections is effective in only one-third of patients, while another treatment, nucleoside analogue therapy, inhibits viral replication without completely eliminating the virus.”
The collaboration is intended to develop a treatment to tackle the disease, Jansen, NTU and NTUH said in a joint statement.
Chen Pei-jer (陳培哲), a professor at the Graduate Institute of Clinical Medicine in NTUH’s Medical College and the principal investigator of the collaboration, said the aim is to “accelerate the development of a new hepatitis B drug by combining the resources uniquely held by the respective partners.”
“NTU has been working in this research field for more than 50 years. NTU’s specialization and experience makes it peerless in the fields of drug research and development,” Chen Pei-jer said.
“Janssen has a large collection of compounds as drug candidates. They need a platform to see whether the candidates are safe and effective,” Chen Pei-jer added.
From the mouse model first established by the NTU research team for assaying anti-viral and immune-modulatory activity — an important indication of HBV eradication — and the woodchuck model, which demonstrates HBV activity most similar to that of human HBV, to recent clinical research, Taiwan has always been a leader in the field of HBV treatment, Chen Pei-jer said, adding that NTU’s research was “a complete line from bench to bedside and back.”
“We are aiming to take the lead in developing a new drug to fully eradicate HBV,” the lead investigator said.
The first of 10 new high-capacity trains purchased from South Korea’s Hyundai Rotem arrived at the Port of Taipei yesterday to meet the demands of an expanding metro network, Taipei Rapid Transit Corp (TRTC) said yesterday. The train completed a three-day, 1,200km voyage from the Port of Masan in South Korea, the company said. Costing NT$590 million (US$18.79 million) each, the new six-carriage trains feature a redesigned interior based on "human-centric" transportation concepts, TRTC said. The design utilizes continuous longitudinal seating to widen the aisles and optimize passenger flow, while also upgrading passenger information displays and driving control systems for a more comfortable
Taiwan's first indigenous defense submarine, the SS-711 Hai Kun (海鯤, or Narwhal), departed for its 13th sea trial at 7am today, marking its seventh submerged test, with delivery to the navy scheduled for July. The outing also marked its first sea deployment since President William Lai (賴清德) boarded the submarine for an inspection on March 19, drawing a crowd of military enthusiasts who gathered to show support. The submarine this morning departed port accompanied by CSBC Corp’s Endeavor Manta (奮進魔鬼魚號) uncrewed surface vessel and a navy M109 assault boat. Amid public interest in key milestones such as torpedo-launching operations and overnight submerged trials,
Quarantine awareness posters at Taiwan Taoyuan International Airport have gone viral for their use of wordplay. Issued by the airport branch of the Animal and Plant Health Inspection Agency, the posters feature sniffer dogs making a range of facial expressions, paired with advisory messages built around homophones. “We update the messages for holidays and campaign needs, periodically refreshing materials to attract people’s attention,” quarantine officials said. “The aim is to use the dogs’ appeal to draw focus to quarantine regulations.” A Japanese traveler visiting Taiwan has posted a photo on X of a poster showing a quarantine dog with a
Taiwan’s coffee community has launched a “one-person-one-e-mail” campaign, calling for people to send a protest-e-mail to the World Coffee Championships (WCC) urging it to redesignate Taiwanese competitors as from “Taiwan,” rather than “Chinese Taipei.” The call followed sudden action last week after the WCC changed all references to Taiwanese competitors from “Taiwan” to “Chinese Taipei,” including recent World Latte Art champion Bala (林紹興), who won the World Latte Art Championship in San Diego earlier this month. When Bala received the trophy, he was referred to as representing Taiwan, as well as in the announcement on the WCC’s Web site, until it
RSS